TORRENT PHARMACEUTICALS Q4 Result NET PROFIT UP 11 % AT 498 CR (YOY), DOWN 1 % (QOQ) REVENUE UP 8 % AT 2959 CR (YOY) ,UP 5 % (QOQ) EBITDA UP 9 % AT 964 CR (YOY),UP 5 %(QOQ) MARGINS AT 32.57 % V 32.15 % (YOY), 32.5% (QOQ)